| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 15 | 2023 | 133 | 2.780 |
Why?
|
| Multiple Sclerosis | 8 | 2023 | 93 | 2.200 |
Why?
|
| PPAR alpha | 12 | 2023 | 55 | 2.080 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 9 | 2023 | 60 | 1.790 |
Why?
|
| Gemfibrozil | 8 | 2023 | 29 | 1.450 |
Why?
|
| Mice | 34 | 2023 | 1345 | 1.440 |
Why?
|
| Interleukin-12 | 6 | 2023 | 33 | 1.310 |
Why?
|
| Myelin Sheath | 3 | 2017 | 22 | 1.230 |
Why?
|
| Oligodendroglia | 5 | 2017 | 36 | 1.180 |
Why?
|
| Gene Expression Regulation | 6 | 2015 | 262 | 1.170 |
Why?
|
| Animals | 36 | 2023 | 3510 | 1.160 |
Why?
|
| Astrocytes | 9 | 2021 | 141 | 1.100 |
Why?
|
| Macrophages, Peritoneal | 4 | 2014 | 14 | 1.060 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2023 | 7 | 0.840 |
Why?
|
| PPAR-beta | 3 | 2015 | 11 | 0.830 |
Why?
|
| Interleukin-23 | 4 | 2023 | 18 | 0.800 |
Why?
|
| Cytokines | 7 | 2021 | 212 | 0.690 |
Why?
|
| Interleukin-12 Subunit p40 | 4 | 2020 | 22 | 0.650 |
Why?
|
| Sodium Chloride | 1 | 2017 | 32 | 0.570 |
Why?
|
| Cells, Cultured | 12 | 2020 | 495 | 0.560 |
Why?
|
| Peptide Fragments | 3 | 2021 | 71 | 0.540 |
Why?
|
| Hippocampus | 5 | 2023 | 262 | 0.520 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2005 | 182 | 0.510 |
Why?
|
| RNA, Messenger | 7 | 2023 | 284 | 0.510 |
Why?
|
| Dopaminergic Neurons | 3 | 2021 | 44 | 0.480 |
Why?
|
| Hypolipidemic Agents | 2 | 2012 | 25 | 0.470 |
Why?
|
| Disease Models, Animal | 7 | 2023 | 584 | 0.460 |
Why?
|
| Up-Regulation | 6 | 2019 | 150 | 0.460 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2018 | 28 | 0.460 |
Why?
|
| Interleukin-7 | 1 | 2014 | 12 | 0.460 |
Why?
|
| Signal Transduction | 8 | 2021 | 410 | 0.450 |
Why?
|
| Receptors, Interleukin-12 | 4 | 2020 | 14 | 0.450 |
Why?
|
| Alzheimer Disease | 6 | 2023 | 1962 | 0.440 |
Why?
|
| Nerve Tissue Proteins | 2 | 2012 | 140 | 0.440 |
Why?
|
| Neurons | 6 | 2019 | 315 | 0.440 |
Why?
|
| Aspirin | 3 | 2018 | 74 | 0.440 |
Why?
|
| Neuroglia | 3 | 2023 | 47 | 0.410 |
Why?
|
| Inflammation | 6 | 2021 | 261 | 0.410 |
Why?
|
| Nitric Oxide Synthase | 5 | 2005 | 41 | 0.400 |
Why?
|
| Mice, Knockout | 6 | 2016 | 284 | 0.400 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 6 | 2005 | 16 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 9 | 2021 | 405 | 0.380 |
Why?
|
| Peptides | 3 | 2021 | 104 | 0.380 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 5 | 2018 | 34 | 0.360 |
Why?
|
| Amyloid beta-Peptides | 3 | 2023 | 315 | 0.350 |
Why?
|
| Plaque, Amyloid | 3 | 2023 | 138 | 0.340 |
Why?
|
| Lysosomes | 3 | 2018 | 21 | 0.340 |
Why?
|
| Interleukin-16 | 1 | 2008 | 6 | 0.320 |
Why?
|
| Interleukin-12 Receptor beta 1 Subunit | 1 | 2008 | 2 | 0.320 |
Why?
|
| Lymphotoxin-alpha | 1 | 2008 | 3 | 0.320 |
Why?
|
| Cinnamates | 2 | 2018 | 8 | 0.310 |
Why?
|
| Lipopolysaccharides | 4 | 2018 | 108 | 0.300 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2018 | 100 | 0.300 |
Why?
|
| Cell Separation | 2 | 2007 | 28 | 0.290 |
Why?
|
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 16 | 0.290 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2008 | 123 | 0.290 |
Why?
|
| Brain | 5 | 2021 | 1560 | 0.270 |
Why?
|
| NF-kappa B | 9 | 2021 | 96 | 0.270 |
Why?
|
| Humans | 19 | 2023 | 25692 | 0.270 |
Why?
|
| Nitric Oxide Synthase Type II | 6 | 2012 | 66 | 0.270 |
Why?
|
| Memory | 3 | 2018 | 296 | 0.270 |
Why?
|
| Promoter Regions, Genetic | 5 | 2019 | 89 | 0.250 |
Why?
|
| Oxidation-Reduction | 1 | 2005 | 59 | 0.250 |
Why?
|
| Myelin Basic Protein | 5 | 2005 | 22 | 0.240 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2021 | 75 | 0.240 |
Why?
|
| PPAR gamma | 3 | 2015 | 14 | 0.230 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2018 | 13 | 0.230 |
Why?
|
| Interleukin-2 | 1 | 2023 | 22 | 0.220 |
Why?
|
| Protein Subunits | 1 | 2003 | 16 | 0.220 |
Why?
|
| T-Lymphocytes | 5 | 2008 | 88 | 0.210 |
Why?
|
| Macrophages | 1 | 2023 | 97 | 0.210 |
Why?
|
| Response Elements | 2 | 2013 | 15 | 0.210 |
Why?
|
| Molecular Chaperones | 1 | 2023 | 7 | 0.210 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 66 | 0.200 |
Why?
|
| Transcriptional Activation | 3 | 2018 | 30 | 0.200 |
Why?
|
| CD40 Antigens | 1 | 2002 | 6 | 0.200 |
Why?
|
| CD40 Ligand | 1 | 2002 | 8 | 0.200 |
Why?
|
| Syzygium | 1 | 2021 | 2 | 0.190 |
Why?
|
| Antibodies | 1 | 2002 | 48 | 0.190 |
Why?
|
| Female | 14 | 2021 | 14273 | 0.190 |
Why?
|
| Cell Line | 5 | 2018 | 268 | 0.180 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2021 | 25 | 0.180 |
Why?
|
| Fever | 1 | 2021 | 30 | 0.180 |
Why?
|
| Lung Diseases | 1 | 2021 | 42 | 0.180 |
Why?
|
| Lung | 1 | 2021 | 159 | 0.180 |
Why?
|
| Primary Cell Culture | 3 | 2015 | 23 | 0.180 |
Why?
|
| Heart Diseases | 1 | 2021 | 60 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2016 | 325 | 0.170 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2019 | 12 | 0.160 |
Why?
|
| Transfection | 3 | 2018 | 112 | 0.160 |
Why?
|
| Interleukin-6 | 3 | 2021 | 74 | 0.160 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2018 | 49 | 0.150 |
Why?
|
| Recombinant Proteins | 2 | 2020 | 201 | 0.150 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 45 | 0.150 |
Why?
|
| Dopamine | 1 | 2018 | 85 | 0.150 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2018 | 7 | 0.150 |
Why?
|
| Protein Binding | 4 | 2021 | 116 | 0.150 |
Why?
|
| Parkinsonian Disorders | 1 | 2021 | 210 | 0.150 |
Why?
|
| Phosphorylation | 1 | 2017 | 134 | 0.140 |
Why?
|
| Interferon-gamma | 4 | 2007 | 75 | 0.140 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2007 | 33 | 0.140 |
Why?
|
| Interleukin-1 | 3 | 2005 | 48 | 0.140 |
Why?
|
| Hydroxybutyrates | 1 | 2016 | 7 | 0.140 |
Why?
|
| Dimerization | 2 | 2008 | 19 | 0.130 |
Why?
|
| Luciferases | 2 | 2014 | 26 | 0.130 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2015 | 8 | 0.130 |
Why?
|
| Food Preservatives | 1 | 2015 | 9 | 0.130 |
Why?
|
| Cinnamomum zeylanicum | 1 | 2015 | 22 | 0.120 |
Why?
|
| Simvastatin | 1 | 2015 | 14 | 0.120 |
Why?
|
| Sodium Benzoate | 1 | 2015 | 19 | 0.120 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 217 | 0.120 |
Why?
|
| Inflammation Mediators | 2 | 2021 | 65 | 0.120 |
Why?
|
| Nerve Growth Factors | 1 | 2015 | 37 | 0.120 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 53 | 0.120 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2014 | 4 | 0.120 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2014 | 13 | 0.110 |
Why?
|
| Genes, Reporter | 1 | 2014 | 22 | 0.110 |
Why?
|
| Adoptive Transfer | 2 | 2004 | 26 | 0.110 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2013 | 25 | 0.110 |
Why?
|
| Demyelinating Diseases | 1 | 2012 | 14 | 0.100 |
Why?
|
| Transcription Factor RelA | 3 | 2007 | 14 | 0.100 |
Why?
|
| CD11b Antigen | 1 | 2012 | 14 | 0.100 |
Why?
|
| Nitric Oxide | 4 | 2005 | 75 | 0.100 |
Why?
|
| HEK293 Cells | 2 | 2021 | 62 | 0.100 |
Why?
|
| Male | 8 | 2021 | 13917 | 0.090 |
Why?
|
| Parkinson Disease | 1 | 2018 | 776 | 0.090 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2008 | 6 | 0.080 |
Why?
|
| DNA, Complementary | 1 | 2008 | 22 | 0.080 |
Why?
|
| Interleukin-1beta | 2 | 2007 | 51 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 55 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2008 | 48 | 0.080 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 72 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 128 | 0.070 |
Why?
|
| Enzyme Induction | 2 | 2005 | 18 | 0.070 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2007 | 3 | 0.070 |
Why?
|
| Gene Expression | 1 | 2008 | 182 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2007 | 36 | 0.070 |
Why?
|
| Transcription, Genetic | 4 | 2013 | 100 | 0.070 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2007 | 6 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 14 | 0.070 |
Why?
|
| Phagocytosis | 1 | 2007 | 38 | 0.070 |
Why?
|
| Motor Activity | 2 | 2021 | 304 | 0.070 |
Why?
|
| DNA | 1 | 2007 | 95 | 0.070 |
Why?
|
| Cell Survival | 1 | 2007 | 110 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2003 | 32 | 0.070 |
Why?
|
| Integrin alpha4beta1 | 2 | 2003 | 5 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 341 | 0.070 |
Why?
|
| Synapses | 2 | 2018 | 32 | 0.060 |
Why?
|
| Pregnancy | 1 | 2007 | 291 | 0.060 |
Why?
|
| Myelin Proteins | 1 | 2005 | 2 | 0.060 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2005 | 2 | 0.060 |
Why?
|
| Sulfhydryl Compounds | 1 | 2005 | 3 | 0.060 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2005 | 3 | 0.060 |
Why?
|
| Thiocarbamates | 1 | 2005 | 6 | 0.060 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2005 | 5 | 0.060 |
Why?
|
| Proline | 1 | 2005 | 9 | 0.060 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2005 | 8 | 0.060 |
Why?
|
| Pyrrolidines | 1 | 2005 | 11 | 0.060 |
Why?
|
| Acetylcysteine | 1 | 2005 | 14 | 0.060 |
Why?
|
| DNA Primers | 1 | 2005 | 46 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2005 | 36 | 0.060 |
Why?
|
| Oxidants | 1 | 2005 | 25 | 0.060 |
Why?
|
| Neurodegenerative Diseases | 1 | 2007 | 117 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2005 | 94 | 0.060 |
Why?
|
| Antioxidants | 1 | 2005 | 57 | 0.060 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 14 | 0.060 |
Why?
|
| Transcription Factor AP-1 | 1 | 2005 | 16 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2005 | 103 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 32 | 0.060 |
Why?
|
| Time Factors | 2 | 2005 | 1336 | 0.060 |
Why?
|
| Phenylacetates | 1 | 2003 | 5 | 0.050 |
Why?
|
| Tyrosine | 1 | 2003 | 25 | 0.050 |
Why?
|
| ADAM10 Protein | 1 | 2023 | 3 | 0.050 |
Why?
|
| Administration, Oral | 2 | 2019 | 103 | 0.050 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2023 | 12 | 0.050 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2023 | 20 | 0.050 |
Why?
|
| Gene Products, tat | 1 | 2002 | 3 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2003 | 124 | 0.050 |
Why?
|
| Ocimum sanctum | 1 | 2021 | 2 | 0.050 |
Why?
|
| Eugenol | 1 | 2021 | 2 | 0.050 |
Why?
|
| Spices | 1 | 2021 | 2 | 0.050 |
Why?
|
| A549 Cells | 1 | 2021 | 8 | 0.050 |
Why?
|
| Adult | 2 | 2020 | 7336 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2023 | 151 | 0.050 |
Why?
|
| Locomotion | 1 | 2021 | 24 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 33 | 0.050 |
Why?
|
| Cytochrome P-450 CYP2C8 Inhibitors | 1 | 2021 | 3 | 0.050 |
Why?
|
| Neutrophil Infiltration | 1 | 2021 | 9 | 0.050 |
Why?
|
| Administration, Intranasal | 1 | 2021 | 27 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 51 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 62 | 0.040 |
Why?
|
| Th17 Cells | 1 | 2020 | 25 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2015 | 108 | 0.040 |
Why?
|
| Immunoblotting | 3 | 2005 | 50 | 0.040 |
Why?
|
| Fenofibrate | 1 | 2019 | 4 | 0.040 |
Why?
|
| Base Sequence | 1 | 2019 | 90 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2015 | 158 | 0.040 |
Why?
|
| Organelle Biogenesis | 1 | 2018 | 3 | 0.040 |
Why?
|
| Substantia Nigra | 1 | 2019 | 111 | 0.040 |
Why?
|
| CREB-Binding Protein | 1 | 2018 | 6 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 38 | 0.040 |
Why?
|
| alpha-Synuclein | 1 | 2018 | 115 | 0.030 |
Why?
|
| Palmitic Acids | 1 | 2016 | 7 | 0.030 |
Why?
|
| Oleic Acids | 1 | 2016 | 5 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 35 | 0.030 |
Why?
|
| Ligands | 1 | 2016 | 37 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2016 | 79 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2015 | 12 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2015 | 32 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 35 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 24 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2015 | 40 | 0.030 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2015 | 4 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2015 | 9 | 0.030 |
Why?
|
| Tretinoin | 1 | 2015 | 13 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 13 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 36 | 0.030 |
Why?
|
| Autophagy | 1 | 2015 | 27 | 0.030 |
Why?
|
| Cognition | 1 | 2023 | 1265 | 0.030 |
Why?
|
| Genes, Dominant | 2 | 2005 | 10 | 0.030 |
Why?
|
| Maze Learning | 1 | 2013 | 15 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2013 | 60 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2003 | 26 | 0.030 |
Why?
|
| Spinal Cord | 2 | 2004 | 71 | 0.030 |
Why?
|
| Coculture Techniques | 2 | 2003 | 27 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2003 | 107 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2003 | 118 | 0.030 |
Why?
|
| Calcium | 1 | 2013 | 364 | 0.020 |
Why?
|
| Acetylation | 1 | 2007 | 13 | 0.020 |
Why?
|
| GATA3 Transcription Factor | 1 | 2007 | 4 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2007 | 15 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2007 | 20 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2007 | 23 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2007 | 66 | 0.020 |
Why?
|
| Castration | 1 | 2005 | 5 | 0.020 |
Why?
|
| RNA | 1 | 2005 | 36 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 52 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2005 | 73 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2005 | 51 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2005 | 85 | 0.020 |
Why?
|
| Spleen | 1 | 2004 | 32 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 45 | 0.010 |
Why?
|
| Sex Factors | 1 | 2005 | 427 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2004 | 96 | 0.010 |
Why?
|
| Mutation | 1 | 2005 | 325 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 6 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2003 | 11 | 0.010 |
Why?
|
| Interleukins | 1 | 2003 | 22 | 0.010 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2003 | 16 | 0.010 |
Why?
|
| Phenylbutyrates | 1 | 2003 | 7 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 40 | 0.010 |
Why?
|
| Cell Movement | 1 | 2003 | 70 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2003 | 78 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2003 | 66 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 21 | 0.010 |
Why?
|
| Integrin alpha4 | 1 | 2002 | 3 | 0.010 |
Why?
|
| eIF-2 Kinase | 1 | 2002 | 7 | 0.010 |
Why?
|
| Flavonoids | 1 | 2002 | 17 | 0.010 |
Why?
|
| Interferon-beta | 1 | 2002 | 6 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 79 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2003 | 127 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 140 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 187 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2003 | 403 | 0.010 |
Why?
|
| Disease Progression | 1 | 2003 | 664 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 913 | 0.010 |
Why?
|